Analyst Research Report Snapshot

Title:

Alliance Pharma (APH.L) Pre-close update

Price:

$46.00

Provider:

Hardman & Company

Date:

11 Jul 2013

Pages:

5

Type:

AcrobatPDF

Companies referenced:

ALAPH.L

Available for Immediate Download
Summary:

Alliance Pharma has made a good start to FY13, with 1H13 trading in-line with management expectations. Despite certain headwinds, revenues increased 4% to £22.8m in 1H13 (HR forecast of £22.6m). Cornerstone products are performing well and recent acquisitions are ahead. That said, momentum in FY14 will be constrained by a further delay to Immucyst supplies and the pharma pricing review.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.